Explore more publications!
My Africa News Online
Got News to Share?

My Africa News Online: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on My Africa News Online.

November 2025

Mo Tu We Th Fr Sa Su
1 2
3 4 5 6 7 8 9
10 11 12 13 14 15 16
17 18 19 20 21 22 23
24 25 26 27 28 29 30

December 2025

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30 31

January 2026

Mo Tu We Th Fr Sa Su
1 2 3 4
5 6 7 8 9 10 11
12 13 14 15 16 17 18
19 20 21 22 23 24 25
26 27 28 29 30 31

Press releases published on November 13, 2025

Outlook Therapeutics Announces Acceptance of Biologics License Application by U.S. FDA for ONS-5010 as a Treatment for Wet AMD
November 13, 2025

Outlook Therapeutics Announces Acceptance of Biologics License Application by U.S. FDA for ONS-5010 as a Treatment for Wet AMD

Indeterminate GlobeNewswire
ESGold Corp. (CSE: ESAU) (OTCQB: ESAUF) Positioned to Meet Growing Demand for Precious Metals
November 13, 2025

ESGold Corp. (CSE: ESAU) (OTCQB: ESAUF) Positioned to Meet Growing Demand for Precious Metals

Indeterminate GlobeNewswire
AEON Biopharma Reports Positive and Robust Biosimilarity Results: Identical Amino Acid Sequence and Highly Similar Functional Analysis Data
November 13, 2025

AEON Biopharma Reports Positive and Robust Biosimilarity Results: Identical Amino Acid Sequence and Highly Similar Functional Analysis Data

Indeterminate GlobeNewswire
AEON Biopharma Announces Fundraise Totaling Up to ~$22 Million through Private Placement and Proposed Exchange of Daewoong Convertible Notes
November 13, 2025

AEON Biopharma Announces Fundraise Totaling Up to ~$22 Million through Private Placement and Proposed Exchange of Daewoong Convertible Notes

Indeterminate GlobeNewswire
Fate Therapeutics Reports Third Quarter 2025 Financial Results and Business Updates
November 13, 2025

Fate Therapeutics Reports Third Quarter 2025 Financial Results and Business Updates

Indeterminate GlobeNewswire
Biofrontera Inc. Reports Third Quarter 2025 Financial Results and Provides a Business Update
November 13, 2025

Biofrontera Inc. Reports Third Quarter 2025 Financial Results and Provides a Business Update

Indeterminate GlobeNewswire
Matisse Pharmaceuticals successfully completes study with prolonged infusion of M6229 in healthy volunteers
November 13, 2025

Matisse Pharmaceuticals successfully completes study with prolonged infusion of M6229 in healthy volunteers

Indeterminate GlobeNewswire
GenoSafe strengthens its leadership in analytical expertise with the opening of new GMP-compliant laboratories to support the advanced therapies sector
November 13, 2025

GenoSafe strengthens its leadership in analytical expertise with the opening of new GMP-compliant laboratories to support the advanced therapies sector

Indeterminate GlobeNewswire
GenoSafe étend son leadership en expertise analytique avec l’ouverture de nouveaux laboratoires aux standards internationaux pour soutenir la filière des thérapies innovantes
November 13, 2025

GenoSafe étend son leadership en expertise analytique avec l’ouverture de nouveaux laboratoires aux standards internationaux pour soutenir la filière des thérapies innovantes

Indeterminate GlobeNewswire
Vivex Biologics Announces Publication of a Real-World Evidence Study Demonstrating Superior or Similar Outcomes for Cygnus® Amnion-Based Skin Substitutes in Wound Care
November 13, 2025

Vivex Biologics Announces Publication of a Real-World Evidence Study Demonstrating Superior or Similar Outcomes for Cygnus® Amnion-Based Skin Substitutes in Wound Care

Indeterminate GlobeNewswire
Clene Reports Third Quarter 2025 Financial Results and Recent Operating Highlights
November 13, 2025

Clene Reports Third Quarter 2025 Financial Results and Recent Operating Highlights

Indeterminate GlobeNewswire
AI Enhanced 3D Model Defines a Potential District Scale Gold and Silver System at ESGold’s Montauban Project
November 13, 2025

AI Enhanced 3D Model Defines a Potential District Scale Gold and Silver System at ESGold’s Montauban Project

Indeterminate GlobeNewswire
Century Therapeutics Reports Third Quarter 2025 Financial Results and Provides Business Update
November 13, 2025

Century Therapeutics Reports Third Quarter 2025 Financial Results and Provides Business Update

Indeterminate GlobeNewswire
Dynacor Reports Record Sales and EBITDA in Q3-2025
November 13, 2025

Dynacor Reports Record Sales and EBITDA in Q3-2025

Indeterminate GlobeNewswire
PDS Biotech Reports Third Quarter 2025 Financial Results and Provides Clinical Programs Update
November 13, 2025

PDS Biotech Reports Third Quarter 2025 Financial Results and Provides Clinical Programs Update

Indeterminate GlobeNewswire
Dynacor annonce des ventes et un BAIIA records au troisième trimestre de 2025
November 13, 2025

Dynacor annonce des ventes et un BAIIA records au troisième trimestre de 2025

Indeterminate GlobeNewswire
Century Therapeutics Announces New Beta Islet Program for Type 1 Diabetes
November 13, 2025

Century Therapeutics Announces New Beta Islet Program for Type 1 Diabetes

Indeterminate GlobeNewswire
Medicenna Therapeutics Reports Second Quarter Fiscal 2026 Financial Results and Provides a Corporate Update
November 13, 2025

Medicenna Therapeutics Reports Second Quarter Fiscal 2026 Financial Results and Provides a Corporate Update

Indeterminate GlobeNewswire
Applied Therapeutics Reports Third Quarter 2025 Financial Results 
November 13, 2025

Applied Therapeutics Reports Third Quarter 2025 Financial Results 

Indeterminate GlobeNewswire
Critical One Energy Appoints Chief Geological Officer to Advance Flagship Antimony-Gold Project
November 13, 2025

Critical One Energy Appoints Chief Geological Officer to Advance Flagship Antimony-Gold Project

Indeterminate GlobeNewswire
Show More

Share us

on your social networks:
Facebook Facebook LinkedIn LinkedIn
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions